Gene · 5934
RBL2: RB transcriptional corepressor like 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RBL2: RB transcriptional corepressor like 2. Genes, record 5934. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5934
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q08999 | Retinoblastoma-like protein 2 | 1,139 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents36
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 2018 | Q08999 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1583 | Q08999 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4532 | Q08999 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1583 | Q08999 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2018 | Q08999 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4532 | Q08999 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 8179 | Q08999 | Espacenet |
| JP 2023123507 A | 2023-09-05 | 142 | Q08999 | Espacenet |
| US 11708396 B2 | 2023-07-25 | 2333 | Q08999 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 72906 | Q08999 | Espacenet |
1 to 10 of 36
See all 36 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,190
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RBL2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 16 | 2025 |
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 14 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 13 | 2025 |
| U24CA213274 | Coordinating center for the NCI small cell lung cancer research consortium | 8 | 2025 |
| P01CA019014 | Viral Oncogenesis, Latency, and Replication | 7 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 7 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 6 | 2025 |
| P50CA168504 | Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer | 6 | 2025 |
1 to 10 of 2,190Source NIH's project files
See all 2,190 nih grantsPapers3,186
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Senescence-Associated Checkpoint Gene Dysregulation in Established Osteoarthritis: Integrated Transcriptomic Analysis and In Vitro Evaluation of CDK6 and WEE1. | Biomedicines | 2026 | 42792657 | PubTator, text mining | PubMed |
| Cancer Stem Cell Quiescence: Molecular and Microenvironmental Evidence for an Actively Regulated Adaptive Survival Strategy. | Cancer Med | 2026 | 42768738 | PubTator, text mining | PubMed |
| Ginsenosides Rb1 and Rg1 Suppress Lipopolysaccharide-Induced Inflammatory Gene Expression in Microglia and Astrocytes, Unlike Rb2. | Pharmacol Res Perspect | 2026 | 42762468 | PubTator, text mining | PubMed |
| Predicting gene compensation in disease with graph embedding techniques. | Artif Intell Med | 2026 | 42632343 | PubTator, text mining | PubMed |
| Targeting Hsc70-mediated mitochondrial-lipid droplet crosstalk via Ginsenoside Rb2 promotes post-infarction cardiomyocyte regeneration. | Pharmacol Res | 2026 | 42309496 | PubTator, text mining | PubMed |
| Research Progress on Anticancer Mechanism of Ginsenoside Regulating Tumor Microenvironment. | Curr Issues Mol Biol | 2026 | 41899480 | PubTator, text mining | PubMed |
| Unraveling small non-coding RNAs with a significant post-transcriptional impact on breast cancer cell signaling, using a combinational sequencing approach. | Funct Integr Genomics | 2026 | 41866548 | PubTator, text mining | PubMed |
| Exploiting cellular senescence in hematologic malignancies. | Transl Oncol | 2026 | 41844438 | PubTator, text mining | PubMed |
| Targeting Autophagy in Ovarian Cancer: The Emerging Role of Ginsenosides. | Cancer Med | 2026 | 41811763 | PubTator, text mining | PubMed |
| Generalized Surface Conductivity Model for Anisotropic Phonon Polaritons in van der Waals Slabs. | Nanophotonics | 2026 | 41798987 | PubTator, text mining | PubMed |
1 to 10 of 3,186
See all 3,186 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5934
GET https://conductscience.org/api/genes/v1/5934/patents?page=2